JP2024511953A5 - - Google Patents

Info

Publication number
JP2024511953A5
JP2024511953A5 JP2023555729A JP2023555729A JP2024511953A5 JP 2024511953 A5 JP2024511953 A5 JP 2024511953A5 JP 2023555729 A JP2023555729 A JP 2023555729A JP 2023555729 A JP2023555729 A JP 2023555729A JP 2024511953 A5 JP2024511953 A5 JP 2024511953A5
Authority
JP
Japan
Prior art keywords
spinosin
days
mammal
group
approximately
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023555729A
Other languages
English (en)
Japanese (ja)
Other versions
JP7900407B2 (ja
JP2024511953A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/019870 external-priority patent/WO2022192618A1/en
Publication of JP2024511953A publication Critical patent/JP2024511953A/ja
Publication of JP2024511953A5 publication Critical patent/JP2024511953A5/ja
Application granted granted Critical
Publication of JP7900407B2 publication Critical patent/JP7900407B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023555729A 2021-03-11 2022-03-11 哺乳動物においてダニの侵入を防除するための餌および方法 Active JP7900407B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163159644P 2021-03-11 2021-03-11
US63/159,644 2021-03-11
PCT/US2022/019870 WO2022192618A1 (en) 2021-03-11 2022-03-11 Feed and methods for controlling tick infestations in a mammal

Publications (3)

Publication Number Publication Date
JP2024511953A JP2024511953A (ja) 2024-03-18
JP2024511953A5 true JP2024511953A5 (cg-RX-API-DMAC7.html) 2025-03-06
JP7900407B2 JP7900407B2 (ja) 2026-08-04

Family

ID=83227122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023555729A Active JP7900407B2 (ja) 2021-03-11 2022-03-11 哺乳動物においてダニの侵入を防除するための餌および方法

Country Status (10)

Country Link
US (1) US20230413818A1 (cg-RX-API-DMAC7.html)
EP (1) EP4304605A4 (cg-RX-API-DMAC7.html)
JP (1) JP7900407B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230161995A (cg-RX-API-DMAC7.html)
CN (1) CN117377477A (cg-RX-API-DMAC7.html)
AU (1) AU2022234318A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023017501A2 (cg-RX-API-DMAC7.html)
CA (1) CA3211585A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023010379A (cg-RX-API-DMAC7.html)
WO (1) WO2022192618A1 (cg-RX-API-DMAC7.html)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001011963A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Oral treatment of companion animals with ectoparasiticidal spinosyns
CA2544417C (en) 2003-11-04 2012-04-10 Akzo Nobel N.V. Ectoparasiticidal formulations of spinosyns and azole pesticides
UY28617A1 (es) 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
UA108200C2 (uk) * 2009-05-08 2015-04-10 Лікарські форми та способи застосування ектопаразитоцидів
CA2817001C (en) 2010-11-05 2015-09-29 Eli Lilly And Company Methods for inhibiting insect infestations
AP2014007874A0 (en) * 2012-02-06 2014-08-31 Merial Ltd Parasiticidal oral veterinary compositions comprising systemetically- acting active agents, methods and uses thereof
WO2014194503A1 (en) * 2013-06-06 2014-12-11 Eli Lilly And Company Parasiticidal compounds, methods, and formulations
WO2018183512A1 (en) 2017-03-28 2018-10-04 Piedmont Animal Health, Llc Combinations of acaricides and insect growth regulators for control of fleas without emesis in animals
CN110680803A (zh) 2019-10-17 2020-01-14 广东省农业科学院动物卫生研究所 一种塞拉菌素醇质体制剂及其制备方法和应用

Similar Documents

Publication Publication Date Title
KR101653071B1 (ko) 선별적 s1p₁ 수용체 작동약에 대한 투약 섭생
US7462643B1 (en) Essential fatty acids in the prevention of cardiovascular events
JP2021527092A5 (cg-RX-API-DMAC7.html)
JP2023522010A5 (cg-RX-API-DMAC7.html)
CN1124138A (zh) 用于治疗糖尿病并发症的组合物
JP2000512993A (ja) H▲上+▼,k▲上+▼−atpアーゼ阻害剤の投与計画
SK280283B6 (sk) Farmaceutický prostriedok na liečenie žalúdočných
EP3554285A1 (en) Use of nad precursors for improving maternal health and/or offspring health
EP1689382A1 (de) Pharmazeutische zusammensetzung aus einem beta-3-adrenozeptor-agonisten und einem in den prostaglandinstoffwechsel eingreifendem wirkstoff
JP2002504138A (ja) ロシグリタゾンおよびインスリンを用いる糖尿病の治療
CN113194924B (zh) 制备包含task-1和task-3通道抑制剂的药物剂型的方法及其在呼吸障碍治疗中的用途
JP2023542932A5 (cg-RX-API-DMAC7.html)
KR20010015650A (ko) 조합 제제로서의 엔도텔린 길항제 및 베타-수용체 차단제
JPH0529206B2 (cg-RX-API-DMAC7.html)
JP2021520403A (ja) 糖尿病予防・治療用の医薬品組成物及びその用途
JP2024524996A5 (cg-RX-API-DMAC7.html)
CA2684174A1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des desordres moteurs lies a la maladie de parkinson
EP0719552A2 (en) Pharmaceutical composition comprising a quinone derivative or a hydroquinone thereof for treating dermatitis
JP2021091608A5 (cg-RX-API-DMAC7.html)
EA009127B1 (ru) Комбинированное применение фибрата и орлистата для лечения ожирения
US20110269708A1 (en) P2x7 antagonists to treat affective disorders
ESSIG Convulsive and sham rage behaviors in decorticate dogs during barbiturate withdrawal
EA013812B1 (ru) Фармацевтическая композиция блокатора натриевых каналов и селективного ингибитора обратного захвата серотонина
JP2845988B2 (ja) ベンフォチアミン製剤
EA015888B1 (ru) Левозимендан для применения в лечении хронического заболевания клапанов